Blink Anesthesia Reports Strongest Quarter to Date, Driven by U.S. Expansion and Growing Global Adoption of TwitchView®

Blink Anesthesia
Blink Anesthesia-1
Blink Anesthesia Reports Strongest Quarter to Date, Driven by U.S. Expansion and Growing Global Adoption of TwitchView®
2:59

Seattle, WA — Monday, May 4, 2026 - Blink Anesthesia Reports Strongest Quarter to Date, Driven by U.S. Expansion and Growing Global Adoption of TwitchView®

Our customers and team delivered our strongest quarter to date in Q1, continuing the momentum from a profitable 2025.

We expanded our footprint across the U.S., including securing a major contract with a leading academic medical center in the Mid-Atlantic region. This system-wide implementation of more than 130 TwitchView® Systems is on track for completion in Q2. Reflecting the growing importance of permanent placement for quantitative monitors, these systems will be installed using our TwitchArm® mounting solution.

Our existing customers continue to demonstrate confidence in both our technology and our team, with ongoing expansion across broader hospital networks - underscoring the long-term value of partnering with TwitchView.

During Q1, we participated in multiple competitive evaluations and were consistently selected over competing technologies. We expect this momentum to continue, driven by the strength of our next-generation system, our ability to execute system-wide implementations, and strong recommendations from our customer network.

New European clinical guidelines now support the use of EMG monitoring in the youngest patient populations. Today, 6 of the top Children’s Hospitals in the U.S. use TwitchView. We are also expanding our presence in Europe, where we recently won a competitive bidding process to equip all operating rooms in a new state-of-the-art Children’s Hospital.

In Japan, we thank Heiwa Bussan for a successful five-year partnership and are excited to begin a new collaboration with AMCO Incorporated, a leader in delivering innovative medical technologies to the Japanese market.

In Korea, we hold over 60% of the market and are expanding our footprint across the country.

“Our momentum this year reflects continued progress in how clinicians approach neuromuscular monitoring,” said CEO Justin Hulvershorn, MD, PhD.  “As access to accurate, objective data becomes the standard, we’re proud to support clinicians with technology they can rely on every day.”

About Blink Anesthesia:

Blink Device Company, LLC (dba Blink Anesthesia) is a Seattle-based medical device company dedicated to improving patient safety in anesthesia practice. We develop breakthrough anesthesia technology that is designed to improve patient safety. Our flagship product, the TwitchView® Train of Four Monitor, is a quantitative neuromuscular monitor that helps anesthetists eliminate residual paralysis and allows hospitals to align with the 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade. 

Media Contact:

Leslie Aberman 
Strategic Counsel and Business Affairs 
leslie.aberman@blinkdc.com 
Blink Device Company, LLC